BCLS II Investco, LP

Overview

• HeadquartersBoston, United States²
• Legal formLimited Partnership²
• Kind of organizationLimited partnership²
• LEI254900P2XB3MQV35RY62²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O Maples Fiduciary Services (Delaware) Inc., 19807 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 7920380²

See how the biggest companies compare on our leaderboards

Corporate structure

BCLS II Investco, LP sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

1. Mar 31, 2020Founded BCLS II Investco, LP is founded²

Filings

20 filings to the SEC since October 2021: 20 other. The latest 20:

1. Aug 31, 2026N-PX EDGAR
2. Aug 14, 202613F-NT EDGAR
3. May 15, 202613F-NT EDGAR
4. Feb 17, 202613F-NT EDGAR
5. Nov 14, 202513F-NT EDGAR
6. Aug 29, 2025N-PX EDGAR
7. Aug 14, 202513F-NT EDGAR
8. Jul 24, 2025144 EDGAR
9. May 15, 202513F-NT EDGAR
10. Feb 14, 202513F-NT EDGAR
11. Nov 14, 202413F-NT EDGAR
12. Aug 30, 2024N-PX EDGAR
13. Aug 12, 202413F-NT EDGAR
14. May 15, 202413F-NT EDGAR
15. Mar 27, 2024144 EDGAR
16. Feb 13, 202413F-NT EDGAR
17. Nov 14, 202313F-NT EDGAR
18. Aug 14, 202313F-NT EDGAR
19. May 15, 202313F-NT EDGAR
20. Feb 14, 202313F-NT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

BCLS II Investco, LP has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• NewAmsterdam Pharma Co N.V.SCHEDULE 13D/A Dec 2, 2022 to May 14, 2026³